Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 174

1.

Neuropsychological change in patients with schizophrenia after treatment with quetiapine or haloperidol.

Purdon SE, Malla A, Labelle A, Lit W.

J Psychiatry Neurosci. 2001 Mar;26(2):137-49.

2.

Effectiveness of antipsychotic treatments for schizophrenia: interim 6-month analysis from a prospective observational study (IC-SOHO) comparing olanzapine, quetiapine, risperidone, and haloperidol.

Dossenbach M, Erol A, el Mahfoud Kessaci M, Shaheen MO, Sunbol MM, Boland J, Hodge A, O'Halloran RA, Bitter I; IC-SOHO Study Group.

J Clin Psychiatry. 2004 Mar;65(3):312-21.

PMID:
15096069
3.

Neuropsychological change in early phase schizophrenia during 12 months of treatment with olanzapine, risperidone, or haloperidol. The Canadian Collaborative Group for research in schizophrenia.

Purdon SE, Jones BD, Stip E, Labelle A, Addington D, David SR, Breier A, Tollefson GD.

Arch Gen Psychiatry. 2000 Mar;57(3):249-58.

PMID:
10711911
4.

Does cognitive function improve with quetiapine in comparison to haloperidol?

Velligan DI, Newcomer J, Pultz J, Csernansky J, Hoff AL, Mahurin R, Miller AL.

Schizophr Res. 2002 Jan 15;53(3):239-48.

PMID:
11738537
5.
6.

Effects of risperidone and quetiapine on cognition in patients with schizophrenia and predominantly negative symptoms.

Riedel M, Spellmann I, Strassnig M, Douhet A, Dehning S, Opgen-Rhein M, Valdevit R, Engel RR, Kleindienst N, Müller N, Möller HJ.

Eur Arch Psychiatry Clin Neurosci. 2007 Sep;257(6):360-70. Epub 2007 Jul 14.

PMID:
17629731
9.

A post hoc analysis of the impact on hostility and agitation of quetiapine and haloperidol among patients with schizophrenia.

Chengappa KN, Goldstein JM, Greenwood M, John V, Levine J.

Clin Ther. 2003 Feb;25(2):530-41.

PMID:
12749512
10.
11.

Cognitive and psychomotor effects of risperidone in schizophrenia and schizoaffective disorder.

Houthoofd SA, Morrens M, Sabbe BG.

Clin Ther. 2008 Sep;30(9):1565-89. doi: 10.1016/j.clinthera.2008.09.014. Review.

PMID:
18840365
12.

A single-blind, randomized trial comparing quetiapine and haloperidol in the treatment of tardive dyskinesia.

Emsley R, Turner HJ, Schronen J, Botha K, Smit R, Oosthuizen PP.

J Clin Psychiatry. 2004 May;65(5):696-701.

PMID:
15163258
13.

Treatment of cognitive impairment in early psychosis: a comparison of risperidone and haloperidol in a large long-term trial.

Harvey PD, Rabinowitz J, Eerdekens M, Davidson M.

Am J Psychiatry. 2005 Oct;162(10):1888-95.

PMID:
16199835
14.

A multicentre, double-blind, randomized comparison of quetiapine (ICI 204,636, 'Seroquel') and haloperidol in schizophrenia.

Copolov DL, Link CG, Kowalcyk B.

Psychol Med. 2000 Jan;30(1):95-105. Erratum in: Psychol Med 2000 Jul;30(4):991.

PMID:
10722180
15.

Quetiapine in patients with schizophrenia. A high- and low-dose double-blind comparison with placebo. Seroquel Study Group.

Small JG, Hirsch SR, Arvanitis LA, Miller BG, Link CG.

Arch Gen Psychiatry. 1997 Jun;54(6):549-57.

PMID:
9193196
16.

The effectiveness of quetiapine versus conventional antipsychotics in improving cognitive and functional outcomes in standard treatment settings.

Velligan DI, Prihoda TJ, Sui D, Ritch JL, Maples N, Miller AL.

J Clin Psychiatry. 2003 May;64(5):524-31.

PMID:
12755654
17.

Comparison of quetiapine and risperidone in the treatment of schizophrenia: A randomized, double-blind, flexible-dose, 8-week study.

Zhong KX, Sweitzer DE, Hamer RM, Lieberman JA.

J Clin Psychiatry. 2006 Jul;67(7):1093-103.

PMID:
16889453
18.

[Cognition, schizophrenia and the effect of antipsychotics].

Stip E.

Encephale. 2006 May-Jun;32(3 Pt 1):341-50. Review. French.

PMID:
16840928
19.

Cognitive efficacy of quetiapine in early-onset first-episode psychosis: a 12-week open label trial.

Urben S, Baumann P, Barcellona S, Hafil M, Preuss U, Peter-Favre C, Clarke S, Halfon O, Holzer L.

Psychiatr Q. 2012 Sep;83(3):311-24. doi: 10.1007/s11126-011-9201-3.

PMID:
22101738
20.

Effects of quetiapine and haloperidol on body mass index and glycaemic control: a long-term, randomized, controlled trial.

Emsley R, Turner HJ, Schronen J, Botha K, Smit R, Oosthuizen PP.

Int J Neuropsychopharmacol. 2005 Jun;8(2):175-82. Epub 2005 Mar 1.

PMID:
15737251
Items per page

Supplemental Content

Write to the Help Desk